Article Text

Download PDFPDF

#104 Risk factors for sentinel lymph node metastasis in endometrial cancer (TRSGO-SLN-010)
Free
  1. Ibrahim Yalcin1,
  2. Salih Taskin2,
  3. Ozguc Takmaz3,
  4. Fuat Demirkiran4,
  5. Mete Gungor3,
  6. Nedim Tokgozoglu5,
  7. Emine Karabuk3,
  8. Tugan Bese4,
  9. Duygu Altin2,
  10. Hasan Turan6,
  11. Ilker Kahramanoglu7,
  12. Dogan Vatansever8,
  13. Cetin Celik9,
  14. Faruk Kose3,
  15. Hamdullah Sozen10,
  16. Samet Topuz10,
  17. Macit Arvas4,
  18. Firat Ortac2,
  19. Ali Ayhan11 and
  20. Cagatay Taskiran8
  1. 1Ondokuz Mayis University School of Medicine, Samsun, Turkey
  2. 2Ankara University School of Medicine, Ankara, Turkey
  3. 3Acibadem University School of Medicine, Istanbul, Turkey
  4. 4Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey
  5. 5Klinikum Nordfriesland, Husum, Germany
  6. 6Mersin City Hospital, Mersin, Turkey
  7. 7Private Clinic, Istanbul, Turkey
  8. 8Koc University School of Medicine, Istanbul, Turkey
  9. 9Selcuk University School of Medicine, Konya, Turkey
  10. 10Istanbul University School of Medicine, Istanbul, Turkey
  11. 11Baskent University School of Medicine, Ankara, Turkey

Abstract

Introduction/Background There is limited consensus on the optimal management approach for patients experiencing mapping failure in endometrial cancer (EC). Understanding the risk factors that contribute to sentinel lymph node(SLN) metastasis is of paramount importance. This manuscript aims to provide a comprehensive analysis of the risk factors associated with SLN metastasis.

Methodology A total of 874 women with EC were included in this retrospective study. Out of the initial cohort of 874 patients, a total of 793 patients with successful SLN mapping were included and analysed to investigate the risk factors for SLN metastasis in EC.

Results SLN metastasis was detected in 73 (9.2%) patients. Among the metastatic cases, 20 (27.4%) patients had isolated tumour cells (ITC), 17 (23.3%) patients had micrometastasis, and 36 (49.3%) patients had macrometastasis in the sentinel lymph nodes. The results of the univariate analysis demonstrated a significant association between SLN metastasis and several factors, including age over 60 years, histology other than endometrioid, tumor grade 3, deep myometrial invasion, lymphovascular space invasion (LVSI), primary tumour diameter of 2 cm or larger, and cervical stromal invasion (p < 0.05). At the end of multivariate analysis, deep myometrial invasion [odds ratio (OR), 2.42; 95% confidence interval (CI), 1.29–4.56; p = 0.006], LVSI (OR, 7.27; 95% CI, 3.82–13.81; p < 0.001) and cervical stromal invasion (OR, 2.18; 95% CI, 1.13–4.21; p = 0.020) remained as independent risk factors for SLN involvement in women with EC.

Conclusion LVSI, deep myometrial invasion, and cervical stromal invasion emerged as independent risk factors for SLN metastasis in patients diagnosed with EC. In cases where the identified risk factors are absent, the omission of lymphadenectomy may be considered in instances of SLN mapping failure.

Disclosures The authors has no competing financial interests or conflicts of interest to disclose.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.